Inhibition of fibroblast growth by Notch1 signaling is mediated by induction of WNT11-dependent WISP-1

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Liu, Zhao Jun ^a,b   Li, Yan ^a   Tan, Yurong ^a   Xiao, Min ^c   Zhang, Jialin ^a   Radtke, Freddy ^d   Velazquez, Omaida C ^a,b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI   (United States)

^c WISTAR INSTITUTE   (United States)

^d EPFL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CCN PROTEIN; CCN4 PROTEIN; NOTCH1 RECEPTOR; UNCLASSIFIED DRUG; WNT11 PROTEIN; NOTCH1 PROTEIN, HUMAN; NOTCH1 PROTEIN, MOUSE; ONCOPROTEIN; WISP1 PROTEIN, HUMAN; WISP1 PROTEIN, MOUSE; WNT PROTEIN; WNT11 PROTEIN, HUMAN; WNT11 PROTEIN, MOUSE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CELL; CELL ACTIVITY; CELL GROWTH; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; FIBROBLAST; GROWTH INHIBITION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION; ANIMAL; BIOSYNTHESIS; CELL LINE; CYTOLOGY; GENETICS; METABOLISM; MUTATION; PHYSIOLOGY; WNT SIGNALING PATHWAY;

ANIMALS; CCN INTERCELLULAR SIGNALING PROTEINS; CELL LINE; CELL PROLIFERATION; FIBROBLASTS; HUMANS; MICE; MUTATION; PROTO-ONCOGENE PROTEINS; RECEPTOR, NOTCH1; WNT PROTEINS; WNT SIGNALING PATHWAY;

EID: 84862001701     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0038811     Document Type: Article

References (41)

1. Becker V, Muller G, (1998) Biology of fibroblasts. Clinical and Experimental Nephrology 2: 295-301.
2. Ingber DE, (2002) Cancer as a disease of epithelial-mesenchymal interactions and extracellular matrix regulation. Differentiation 70: 547-560.
3. Lynch CC, Matrisian LM, (2002) Matrix metalloproteinases in tumor-host cell communication. Differentiation 70: 561-573.
4. Midwood KS, Williams LV, Schwarzbauer JE, (2004) Tissue repair and the dynamics of the extracellular matrix. Int J Biochem Cell Biol 36: 1031-1037.
5. Dvorak HF, (1986) Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 315: 1650-1659.
6. Orimo A, Weinberg RA, (2006) Stromal fibroblasts in cancer: a novel tumor-promoting cell type. Cell Cycle 5: 1597-1601.
7. Sappino AP, Skalli O, Jackson B, Schurch W, Gabbiani G, (1988) Smooth-muscle differentiation in stromal cells of malignant and non-malignant breast tissues. Int J Cancer 41: 707-712.
8. Ishii G, Sangai T, Oda T, Aoyagi Y, Hasebe T, et al. (2003) Bone-marrow-derived myofibroblasts contribute to the cancer-induced stromal reaction. Biochem Biophys Res Commun 309: 232-240.
9. Kalluri R, Neilson EG, (2003) Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 112: 1776-1784.
10. Artavanis-Tsakonas S, Rand MD, Lake RJ, (1999) Notch signaling: cell fate control and signal integration in development. Science 284: 770-776.
11. Mumm JS, Kopan R, (2000) Notch signaling: from the outside in. Dev Biol 228: 151-165.
12. Radtke F, Raj K, (2003) The role of Notch in tumorigenesis: oncogene or tumour suppressor? Nat Rev Cancer 3: 756-767.
13. Maillard I, Pear WS, (2003) Notch and cancer: best to avoid the ups and downs. Cancer Cell 3: 203-205.
14. Meier F, Nesbit M, Hsu MY, Martin B, Van Belle P, et al. (2000) Human melanoma progression in skin reconstructs: biological significance of bFGF. Am J Pathol 156: 193-200.
15. Balint K, Xiao M, Pinnix CC, Soma A, Veres I, et al. (2005) Activation of Notch1 signaling is required for beta-catenin-mediated human primary melanoma progression. J Clin Invest 115: 3166-3176.
16. Fukunaga-Kalabis M, Martinez G, Telson SM, Liu ZJ, Balint K, et al. (2008) Downregulation of CCN3 expression as a potential mechanism for melanoma progression. Oncogene 27: 2552-2560.
17. Hsu MY, Shih DT, Meier FE, Van Belle P, Hsu JY, et al. (1998) Adenoviral gene transfer of beta3 integrin subunit induces conversion from radial to vertical growth phase in primary human melanoma. Am J Pathol 153: 1435-1442.
18. Pennica D, Swanson TA, Welsh JW, Roy MA, Lawrence DA, et al. (1998) WISP genes are members of the connective tissue growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors. Proc Natl Acad Sci U S A 95: 14717-14722.
19. Sarmento LM, Huang H, Limon A, Gordon W, Fernandes J, et al. (2005) Notch1 modulates timing of G1-S progression by inducing SKP2 transcription and p27 Kip1 degradation. J Exp Med 202: 157-168.
20. Ishikawa Y, Onoyama I, Nakayama KI, Nakayama K, (2008) Notch-dependent cell cycle arrest and apoptosis in mouse embryonic fibroblasts lacking Fbxw7. Oncogene 27: 6164-6174.
21. Urs S, Roudabush A, O'Neill CF, Pinz I, Prudovsky I, et al. (2008) Soluble forms of the Notch ligands Delta1 and Jagged1 promote in vivo tumorigenicity in NIH3T3 fibroblasts with distinct phenotypes. Am J Pathol 173: 865-878.
22. Shao H, Cai L, Grichnik JM, Livingstone AS, Velazquez OC, et al. (2011) Activation of Notch1 signaling in stromal fibroblasts inhibits melanoma growth by upregulating WISP-1. Oncogene 30: 4316-4326.
23. Ross DA, Kadesch T, (2004) Consequences of Notch-mediated induction of Jagged1. Exp Cell Res 296: 173-182.
24. Venkatachalam K, Venkatesan B, Valente AJ, Melby PC, Nandish S, et al. (2009) WISP1, a pro-mitogenic, pro-survival factor, mediates tumor necrosis factor-alpha (TNF-alpha)-stimulated cardiac fibroblast proliferation but inhibits TNF-alpha-induced cardiomyocyte death. J Biol Chem 284: 14414-14427.
25. Desnoyers L, Arnott D, Pennica D, (2001) WISP-1 binds to decorin and biglycan. J Biol Chem 276: 47599-47607.
26. Tanaka S, Sugimachi K, Saeki H, Kinoshita J, Ohga T, et al. (2001) A novel variant of WISP1 lacking a Von Willebrand type C module overexpressed in scirrhous gastric carcinoma. Oncogene 20: 5525-5532.
27. Sakamoto K, Yamaguchi S, Ando R, Miyawaki A, Kabasawa Y, et al. (2002) The nephroblastoma overexpressed gene (NOV/ccn3) protein associates with Notch1 extracellular domain and inhibits myoblast differentiation via Notch signaling pathway. J Biol Chem 277: 29399-29405.
28. Xu L, Corcoran RB, Welsh JW, Pennica D, Levine AJ, (2000) WISP-1 is a Wnt-1- and beta-catenin-responsive oncogene. Genes Dev 14: 585-595.
29. Pandur P, Lasche M, Eisenberg LM, Kuhl M, (2002) Wnt-11 activation of a non-canonical Wnt signalling pathway is required for cardiogenesis. Nature 418: 636-641.
30. Majumdar A, Vainio S, Kispert A, McMahon J, McMahon AP, (2003) Wnt11 and Ret/Gdnf pathways cooperate in regulating ureteric branching during metanephric kidney development. Development 130: 3175-3185.
31. Ueno S, Weidinger G, Osugi T, Kohn AD, Golob JL, et al. (2007) Biphasic role for Wnt/beta-catenin signaling in cardiac specification in zebrafish and embryonic stem cells. Proc Natl Acad Sci U S A 104: 9685-9690.
32. Zhou W, Lin L, Majumdar A, Li X, Zhang X, Liu W, et al. (2007) Modulation of morphogenesis by noncanonical Wnt signaling requires ATF/CREB family-mediated transcriptional activation of TGFbeta2. Nat Genet 39: 1225-1234.
33. Kirikoshi H, Sekihara H, Katoh M, (2001) Molecular cloning and characterization of human WNT11. Int J Mol Med 8: 651-656.
34. Ouko L, Ziegler TR, Gu LH, Eisenberg LM, Yang VW, (2004) Wnt11 signaling promotes proliferation, transformation, and migration of IEC6 intestinal epithelial cells. J Biol Chem 279: 26707-26715.
35. Zhu H, Mazor M, Kawano Y, Walker MM, Leung HY, et al. (2004) Analysis of Wnt gene expression in prostate cancer: mutual inhibition by WNT11 and the androgen receptor. Cancer Res 64: 7918-7926.
36. Lin Z, Reierstad S, Huang CC, Bulun SE, (2007) Novel estrogen receptor-alpha binding sites and estradiol target genes identified by chromatin immunoprecipitation cloning in breast cancer. Cancer Res 67: 5017-5024.
37. Railo A, Nagy II, Kilpelainen P, Vainio S, (2008) Wnt-11 signaling leads to down-regulation of the Wnt/beta-catenin, JNK/AP-1 and NF-kappaB pathways and promotes viability in the CHO-K1 cells. Exp Cell Res 314: 2389-2399.
38. Radtke F, Wilson A, Stark G, Bauer M, van Meerwijk J, et al. (1999) Deficient T cell fate specification in mice with an induced inactivation of Notch1. Immunity 10: 547-558.
39. Hogan B, Beddington R, Costantini F, Lacey E, (1994) Manipulating the Mouse Embryo: A Laboratory Manual (Cold Spring Harbor Laboratory Press, Plainview, N.Y).
40. Liu ZJ, Xiao M, Balint K, Soma A, Pinnix CC, et al. (2006) Inhibition of endothelial cell proliferation by Notch1 signaling is mediated by repressing MAPK and PI3K/Akt pathways and requires MAML1. FASEB J 20: 1009-1011.
41. Fukunaga-Kalabis M, Martinez G, Liu ZJ, Kalabis J, Mrass P, et al. (2006) CCN3 controls 3D spatial localization of melanocytes in the human skin through DDR1. J Cell Biol 175: 563-569.